Saturday 17 October 2026
Export UFPT’s income statement to Excel — free account
UFP Technologies, Inc.
UFPT Healthcare Medical Devices
UFP Technologies, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $602.8 million, up 19.5% from fiscal 2024. In the quarter to June 2026, revenue grew 15.1%, EPS grew 20.6%, free cash flow fell 35.8% and total debt fell 19.6%, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for three.
291.67
5.52
−1.86%
Follow UFPT
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
28.33 | 21.75 | 25.03 | 22.89 |
+8 more quarters Free account |
P/S ratio |
3.25 | 2.46 | 2.84 | 2.57 | |
P/FCF ratio |
33.37 | 21.49 | 21.65 | 17.60 | |
P/Operating CF |
131.44 | 466.54 | 101.59 | 42.85 | |
P/B ratio |
4.44 | 3.41 | 4.04 | 3.81 | |
Price to Tangible BV |
15.70 | 14.32 | 19.98 | 24.30 | |
EV/Sales |
3.44 | 2.67 | 3.05 | 2.81 | |
EV/EBITDA |
18.75 | 14.52 | 16.50 | 15.02 | |
EV/Operating CF |
30.38 | 20.00 | 20.02 | 16.90 | |
EV/FCF |
35.36 | 23.38 | 23.28 | 19.23 | |
Quick Ratio |
1.61 | 1.59 | 1.45 | 1.28 | |
Current Ratio |
3.00 | 2.91 | 2.69 | 2.41 | |
Net Debt/EBITDA |
3.71 | 4.64 | 4.89 | 5.04 | |
Debt/Assets |
19.30% | 22.39% | 22.81% | 24.59% | |
Debt/Equity |
0.28 | 0.34 | 0.35 | 0.40 | |
Asset Turnover |
0.96 | 0.92 | 0.94 | 0.93 | |
Operating CF/Net income |
0.75 | 0.18 | 0.96 | 2.19 | |
Capex/Depreciation |
(0.23) | (0.34) | (0.78) | (0.69) | |
Interest Coverage |
16.42 | 13.45 | 11.14 | 9.77 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
13.08% | 13.63% | 14.08% | 12.34% | |
Intangible Assets out of Total Assets |
0.49 | 0.50 | 0.52 | 0.52 | |
Share Based Compensation of Revenue |
1.85% | 1.77% | 1.61% | 1.27% | |
Graham Net Nets |
0.01 | (0.01) | (0.02) | (0.03) | |
Graham Number |
112.17 | 106.69 | 104.78 | 101.37 | |
Earnings Yield |
3.53% | 4.60% | 3.99% | 4.37% | |
Free Cash Flow Yield |
3.00% | 4.65% | 4.62% | 5.68% | |
Revenue per Share |
22.48 | 19.97 | 19.33 | 20.04 | |
Operating CF per Share |
2.02 | 0.42 | 2.19 | 4.66 | |
Capex per Share |
(0.15) | (0.22) | (0.50) | (0.44) | |
Free Cash Flow per Share |
1.87 | 0.20 | 1.69 | 4.22 | |
Cash per Share |
1.17 | 2.59 | 2.63 | 2.36 | |
Shareholders Equity per Share |
59.74 | 56.84 | 55.01 | 52.37 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
59.74 | 56.84 | 55.01 | 52.37 | |
Free Cash Flow |
14.46 | 1.52 | 12.98 | 32.55 | |
Working Capital |
156.59 | 147.09 | 126.14 | 115.75 | |
Capital Expenditures |
(1.15) | (1.69) | (3.86) | (3.38) | |
Net Current Asset Value |
15.41 | (11.70) | (30.20) | (50.94) | |
EV/EBIT |
22.57 | 17.56 | 19.93 | 18.06 | |
Capex to Sales |
0.01 | 0.01 | 0.03 | 0.02 | |
Price to Operating Income |
21.30 | 16.15 | 18.53 | 16.54 | |
| Other line items | |||||
Average Receivables |
102.00 | 99.74 | 88.94 | 89.20 | |
Average Payables |
27.81 | 29.07 | 24.28 | 27.86 | |
Average Inventory |
92.65 | 91.91 | 87.20 | 87.42 | |
Average Assets |
658.28 | 658.66 | 642.04 | 645.66 | |
Average Common Equity |
423.96 | 399.77 | 383.32 | 366.53 |
Columns are period end dates